Teva: expenditure on research and development 2006-2023
This statistic shows the expenditure of pharmaceutical company Teva for research and development from 2006 to 2023. Teva Pharmaceutical Industries is one of the largest generic drug manufacturers in the world. In 2023, the company invested 953 million U.S. dollars in research and development. However, this was still significantly lower than the expenditures in 2016-2017.